Related Experiment Videos
[Sickle cell anemia: experience in a center].
M Gómez-Chiari1, J Tusell Puigbert, J Ortega Aramburu
1Servicio de Hematología y Oncología. Hospital Materno-Infantil Vall d'Hebron. Barcelona. España. martagochi@terra.es
Anales De Pediatria (Barcelona, Spain : 2003)
|March 12, 2003
Summary
Sickle cell anemia is an emerging disease in Spain, particularly in children. Early diagnosis and preventive treatment are crucial for minimizing complications and improving outcomes.
Area of Science:
- Hematology
- Pediatric Medicine
- Genetics
Context:
- Sickle cell anemia, a structural hemoglobinopathy, causes vaso-occlusive episodes.
- It is prevalent in Black and African populations and emerging in Spain due to migration.
- This study reviews pediatric cases in a Spanish hospital.
Purpose:
- To analyze the clinical presentation, features, and treatment of sickle cell anemia in pediatric patients.
- To understand the disease's epidemiology and complications in a non-endemic setting.
Summary:
- A retrospective study of 22 pediatric patients (diagnosed 1985-2001) revealed mean age of 39 months at diagnosis.
- Abdominal pain was the most common symptom (45%), followed by infections and stroke (13.7%).
- Hydroxyurea, splenectomy, and bone marrow transplant were employed with favorable results.
Impact:
- Early diagnosis and preventive strategies can significantly reduce morbidity.
- Neonatal screening and genetic counseling are recommended for at-risk populations.
- Improved healthcare guidelines are essential for managing this emerging disease in Spain.